Matches in Wikidata for { <http://www.wikidata.org/entity/Q94234953> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q94234953 description "clinical trial" @default.
- Q94234953 description "ensayo clínico" @default.
- Q94234953 description "ensayu clínicu" @default.
- Q94234953 description "klinisch onderzoek" @default.
- Q94234953 description "клінічне випробування" @default.
- Q94234953 description "կլինիկական փորձարկում" @default.
- Q94234953 description "临床试验" @default.
- Q94234953 name "PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy)" @default.
- Q94234953 name "PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy)" @default.
- Q94234953 type Item @default.
- Q94234953 label "PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy)" @default.
- Q94234953 label "PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy)" @default.
- Q94234953 prefLabel "PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy)" @default.
- Q94234953 prefLabel "PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy)" @default.
- Q94234953 P1132 Q94234953-D5B6EE00-0C89-4D1C-9CA2-CC106A0750B0 @default.
- Q94234953 P1476 Q94234953-E9F0E5BE-D164-40BB-B5D1-EAA0AB465E17 @default.
- Q94234953 P17 Q94234953-089C166F-CCBE-4A3F-964F-92AC8FE2D04E @default.
- Q94234953 P17 Q94234953-1B3D2031-A292-4CC7-91CC-2C87FC76FD09 @default.
- Q94234953 P17 Q94234953-636152B0-6F84-4F6C-8CE6-6162B8C6FAE6 @default.
- Q94234953 P1813 Q94234953-FB00A574-41E0-4E23-A61D-E0736BA08395 @default.
- Q94234953 P2899 Q94234953-455FF8B0-C752-49FC-AE32-332D3B2C090C @default.
- Q94234953 P3098 Q94234953-428B4998-8DE6-4612-A276-3066F6293011 @default.
- Q94234953 P31 Q94234953-795777A0-7336-4982-8011-082B33910B49 @default.
- Q94234953 P4844 Q94234953-94AC8961-1B08-4DA9-88FF-D7A112244E96 @default.
- Q94234953 P580 Q94234953-0FE3C93F-2B24-417D-9A53-E55E5CC9509D @default.
- Q94234953 P582 Q94234953-D30229DF-C288-4B1A-A371-6A8099859B30 @default.
- Q94234953 P6099 Q94234953-050A7ABB-4475-4B77-A049-4338E6D50875 @default.
- Q94234953 P6099 Q94234953-5E1DE452-4A3F-4FF0-9D74-579BF740E98D @default.
- Q94234953 P8005 Q94234953-84B8C684-9BE7-4014-B1CE-6A1666A44D05 @default.
- Q94234953 P8363 Q94234953-F0E7559C-D84B-409C-A9B0-80AEA36C1A03 @default.
- Q94234953 P921 Q94234953-944CC63B-B448-4DA8-9044-4D9D37F9E320 @default.
- Q94234953 P921 Q94234953-F6697F27-86E7-4B17-991B-8ABD1D377F45 @default.
- Q94234953 P1132 "+80" @default.
- Q94234953 P1476 "First-in-human, Dose Titration and Expansion Trial to Evaluate Safety, Immunogenicity and Preliminary Efficacy of W_pro1 in Patients With Metastatic Castration Resistant Prostate Cancer and W_pro1 in Combination With Cemiplimab and/or Goserelin Acetate in Patients With High-risk, Localized Prostate Cancer" @default.
- Q94234953 P17 Q145 @default.
- Q94234953 P17 Q183 @default.
- Q94234953 P17 Q28 @default.
- Q94234953 P1813 "PRO-MERIT" @default.
- Q94234953 P2899 "+18" @default.
- Q94234953 P3098 "NCT04382898" @default.
- Q94234953 P31 Q30612 @default.
- Q94234953 P4844 Q1992653 @default.
- Q94234953 P580 "2019-12-19T00:00:00Z" @default.
- Q94234953 P582 "2023-07-01T00:00:00Z" @default.
- Q94234953 P6099 Q42824440 @default.
- Q94234953 P6099 Q5452194 @default.
- Q94234953 P8005 Q76649708 @default.
- Q94234953 P8363 Q78089383 @default.
- Q94234953 P921 Q2378309 @default.
- Q94234953 P921 Q6714984 @default.